CD274 and cancer: Based on the abovementioned display, various personalized therapies are used in clinical practice, for example ICI which are monoclonal antibodies that target PD-1 and PD-L1 interaction that may occur between cancer cells and immune cells or between cancer cells and nerve cells are widely used.